| PRTC's Vedanta Appoints Chief Legal Officer | Reach | 14.10.21 | 12:01:01 |
| Additional Listing | RNS | 12.10.21 | 07:00:05 |
| Vedanta Positive Phase 2 Data in C. Diff Infection | Reach | 05.10.21 | 13:01:07 |
| PRTC's Sonde Launches Mental Health Monitor | Reach | 05.10.21 | 13:00:04 |
Akili/Shionogi Report Positive Ph2 Data in Japan 29 September 2021 13:01:05 | Reach | 29.09.21 | 13:01:05 |
New PureTech Research Published In Nature Journal 20 September 2021 16:02:37 | Reach | 20.09.21 | 16:02:37 |
PRTC to Present at Oppenheimer Healthcare Summit 14 September 2021 12:00:01 | Reach | 14.09.21 | 12:00:01 |
PRTC's Vor Granted FDA Fast Track Designation 10 September 2021 07:00:06 | Reach | 10.09.21 | 07:00:06 |
Total Voting Rights 01 September 2021 07:00:06 | RNS | 01.09.21 | 07:00:06 |
| Half-year Report | RNS | 24.08.21 | 07:00:04 |
| PRTC Presents LYT-100 Ph1 PK & Tolerability at ERS | Reach | 23.08.21 | 12:00:02 |
| Akili Deal Furthers Digital Medicine Leadership | Reach | 17.08.21 | 13:03:01 |
| PRTC Appoints Industry Veteran & Physician as CMO | Reach | 13.08.21 | 12:00:02 |
| PRTC Receives $6.5M; Imbrium to Develop LYT-503 | Reach | 11.08.21 | 12:00:06 |
| Notice of Results | RNS | 03.08.21 | 07:00:09 |
| Total Voting Rights | RNS | 02.08.21 | 07:00:08 |
| PDMR DEALING - PURCHASE OF SHARES | RNS | 23.07.21 | 07:00:09 |
| PRTC’s Akili Releases New Features for EndeavorRx | Reach | 22.07.21 | 13:03:05 |
| PDMR DEALING - PURCHASE OF SHARES | RNS | 22.07.21 | 07:00:07 |
| PureTech’s Vedanta Raises $68M Series D Financing | Reach | 21.07.21 | 12:03:05 |
